|4Jun 14, 4:33 PM ET

COX GEOFFREY F 4

4 · Vaxart, Inc. · Filed Jun 14, 2019

Insider Transaction Report

Form 4
Period: 2019-06-12
Transactions
  • Award

    Stock Option (right to buy)

    2019-06-12+12,70012,700 total
    Exercise: $0.68From: 2020-04-22Exp: 2029-06-11Common Stock (12,700 underlying)
  • Award

    Stock Option (right to buy)

    2019-06-12+9,0009,000 total
    Exercise: $0.68Exp: 2029-06-11Common Stock (9,000 underlying)
Footnotes (2)
  • [F1]The shares subject to this option shall vest annually over three years from the vesting commencement date of February 13, 2018 (the closing date of the merger between privately-held Vaxart, Inc. and Aviragen Therapeutics, Inc.).
  • [F2]The shares subject to this option shall vest on the first anniversary of the 2019 annual meeting of stockholders of the Issuer.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4